Blogs

Central Government’s power of Revocation of Patent in Public Interest

2nd January, 2014 - 3:10 am Categories: IP Litigation IP Practice in India Patent Litigation Patents

Gopikrishnan M and Akash Patel, interns at Khurana and Khurana, Advocates and IP Attorneys, looks at Central Government’s power of Revocation of Patent in Public Interest. The Indian Patent Act,1970(hereinafter Act) empowers the Central Government to revoke any patent granted by the Indian Patent Office if it feels that the said patent is prejudicial to public … Continue reading Central Government’s power of Revocation of Patent in Public Interest

Read more »

Rockstar Consortium US LP et. al.v. Google Inc

23rd December, 2013 - 11:35 am Categories: Patent Litigation Patents

Gopikrishnan M, an intern at Khurana and Khurana, Advocates and IP Attorneys, looks at Google Inc. been accused of infringing technology related to its searching technology itself. Yet another high-tech and high-profile patent war is on, this one involving a combined attack on the search giant’s core technology. Google is being sued for direct patent infringement … Continue reading Rockstar Consortium US LP et. al.v. Google Inc

Read more »

Copyrights Enjoyed By Musicians

16th December, 2013 - 9:10 am Categories: Copyright Litigation IP Practice in India

Sanyukta Biswas, an intern at Khurana and Khurana, Advocates and IP Attorneys, looks at the rights of singer, lyricist and composer that have been incorporated by the 2012 amendment. Once upon a time in India even the most noted of film artists and musicians could not secure themselves financially despite their brilliance. In an infamous legal … Continue reading Copyrights Enjoyed By Musicians

Read more »

Two-Days International Symposium on Strategies for Managing Pharmaceutical, Biotechnology & Chemical Patent Portfolios

13th December, 2013 - 7:42 am Categories: Educational Conferences/ Seminar News & Updates Pharma- biotech- Patent Commercialisation

We are happy to inform you all that IIPRD and Khurana & Khurana, in association with Cantor Colburn (US) and Fukami Patent Office (Japan) are holding an International Patent Symposium covering all major and relevant Pharmaceutical/Biotechnology Related Patent issues in the month of February, 2014 in India. The Two-Days International Symposium would be covering Strategies for Managing … Continue reading Two-Days International Symposium on Strategies for Managing Pharmaceutical, Biotechnology & Chemical Patent Portfolios

Read more »

Sofosbuvir: The Next Pre-Grant Opposition Target by I-MAK

10th December, 2013 - 5:58 am Categories: IP Practice in India Patents

After anti–influenza drug Tamiflu (Oseltamivir Phosphate) and antiretroviral drug Viread, Gilead Sciences is again back in news, this time with its hepatitis C (HCV) drug Sofosbuvir. Like Tamiflu and Viread pre-grant opposition, Sofosbuvir patent application is also facing pre-grant opposition. Non-profit group I-MAK (Initiative for medicines access and knowledge) has filed a pre-grant opposition against … Continue reading Sofosbuvir: The Next Pre-Grant Opposition Target by I-MAK

Read more »

Cadbury Loses Trade Mark Battle

30th November, 2013 - 6:19 am Categories: IP Litigation Trademark Litigation

31st October, 2013 was a dooms day for Cadbury when it lost 4 of its éclair related trademarks on the basis of rectification petitions made by ITC. S. Usha, the Vice-Chairperson of the Intellectual Property Appellate Board (IPAB), ordered with a direction to the Registrar of Trade Marks to remove the trade marks registered under … Continue reading Cadbury Loses Trade Mark Battle

Read more »

Indian Patent Office Rejects Compulsory Licensing Application: BDR Pharmaceuticals Pvt. Ltd. Vs Bristol Myers Squibb

13th November, 2013 - 7:23 am Categories: IP Practice in India

India issued its first CL last year for a Bayer’s kidney liver cancer drug Nexavar to an Indian generic manufacturer Natco on all three grounds of section 84 (1) including reasonable requirement of public not being met, non availability of drug on affordable prices, and non-working of the invention in the territory of India. This … Continue reading Indian Patent Office Rejects Compulsory Licensing Application: BDR Pharmaceuticals Pvt. Ltd. Vs Bristol Myers Squibb

Read more »

Anti Dilution Protection of Trade Mark: Bloomberg Case

12th November, 2013 - 5:45 am Categories: IP Litigation Trademark Litigation

The era of globalisation and internationalisation of trade and commerce has developed certain complex socio legal issues with regard to well known Trade Marks. Trade Marks are territorial in nature, but in the light of globalisation and internationalisation there is need to protect well known trade marks against their dilution beyond geographical limits. A trade … Continue reading Anti Dilution Protection of Trade Mark: Bloomberg Case

Read more »

Quick Glance at Patents (Amendment) Rules, 2013

28th October, 2013 - 5:23 am Categories: IP Practice in India

The Patent (Amendment) Rules, 2013 came in force with effective from 15th October 2013. It appears that the primary aim of the amendment is associated with various procedures as Indian Patent Office starts functioning as International Searching Authority (ISA) and International Preliminary Examining Authority (IPEA) under the PCT. Under the amended rules the sequence listing … Continue reading Quick Glance at Patents (Amendment) Rules, 2013

Read more »

Indian Patent Office is now ISA and IPEA under PCT

16th October, 2013 - 5:33 am Categories: IP Practice in India

The Indian Patent Office is recognised as an International Searching Authority (ISA) and International Preliminary Examining Authority (IPEA) under the Patent Cooperation Treaty (PCT) w.e.f 15th October 2013. This is a major development and in itself is a huge responsibility as well for the Indian Patent Office (IPO). The IPO will now be examining the … Continue reading Indian Patent Office is now ISA and IPEA under PCT

Read more »

Categories

Archives